Xenon Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 01:31 am IST
Xenon Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 47.46 million compared to USD 31.16 million a year ago. Basic loss per share from continuing operations was USD 0.72 compared to USD 0.55 a year ago. Diluted loss per share from continuing operations was USD 0.72 compared to USD 0.55 a year ago.
For the six months, net loss was USD 89.19 million compared to USD 50.83 million a year ago. Basic loss per share from continuing operations was USD 1.36 compared to USD 0.91 a year ago. Diluted loss per share from continuing operations was USD 1.36 compared to USD 0.91 a year ago.